Xtant Medical Reports Second Quarter 2017 Financial Results

BELGRADE, Mont., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Xtantâ„¢ Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today reported its financial results for the quarter ended June 30th, 2017. The Company reported Second Quarter 2017 revenue of approximately $21.4 million and an EBITDA loss of approximately ($2.1) million for the period.

Back to news